- Home
- AXSM vs NOVT Comparison
AXSM vs NOVT Comparison
Compare AXSM & NOVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- NOVT
- Stock Information
- Founded
- AXSM 2012
- NOVT 1968
- Country
- AXSM United States
- NOVT United States
- Employees
- AXSM N/A
- NOVT N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- NOVT Industrial Machinery/Components
- Sector
- AXSM Health Care
- NOVT Miscellaneous
- Exchange
- AXSM Nasdaq
- NOVT Nasdaq
- Market Cap
- AXSM 5.1B
- NOVT 4.6B
- IPO Year
- AXSM 2015
- NOVT N/A
- Fundamental
- Price
- AXSM $100.69
- NOVT $120.56
- Analyst Decision
- AXSM Strong Buy
- NOVT Hold
- Analyst Count
- AXSM 16
- NOVT 1
- Target Price
- AXSM $170.50
- NOVT $160.00
- AVG Volume (30 Days)
- AXSM 627.1K
- NOVT 203.7K
- Earning Date
- AXSM 08-04-2025
- NOVT 08-05-2025
- Dividend Yield
- AXSM N/A
- NOVT N/A
- EPS Growth
- AXSM N/A
- NOVT 1.57
- EPS
- AXSM N/A
- NOVT 1.95
- Revenue
- AXSM $432,157,000.00
- NOVT $951,695,000.00
- Revenue This Year
- AXSM $62.84
- NOVT $5.66
- Revenue Next Year
- AXSM $60.02
- NOVT $7.58
- P/E Ratio
- AXSM N/A
- NOVT $61.72
- Revenue Growth
- AXSM 72.16
- NOVT 6.52
- 52 Week Low
- AXSM $72.02
- NOVT $98.76
- 52 Week High
- AXSM $139.13
- NOVT $187.12
- Technical
- Relative Strength Index (RSI)
- AXSM 37.30
- NOVT 42.16
- Support Level
- AXSM $99.39
- NOVT $121.23
- Resistance Level
- AXSM $112.98
- NOVT $125.38
- Average True Range (ATR)
- AXSM 3.33
- NOVT 2.95
- MACD
- AXSM -0.76
- NOVT -0.72
- Stochastic Oscillator
- AXSM 9.35
- NOVT 2.53
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products includes AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About NOVT Novanta Inc.
Novanta Inc manufactures photonic and motion-control components for original equipment manufacturers in the medical equipment and industrial technology markets. The firm operates in two segments: Automation Enabling Technologies and Medical Solutions. It generates the majority of its revenue from the Medical Solutions segment that designs, manufactures, and markets a range of medical-grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; and wireless technologies. The firm generates the majority of its revenue from the United States and Europe.